Frost & Sullivan, May 2010, Pages: 68
This study encompasses feedback provided by U.S. diabetes patients on aspects of drug delivery and drug treatment for diabetes, enabling interested stakeholders to gain insight into current
Frost & Sullivan, May 2010, Pages: 47
This study encompasses feedback provided by U.S. physicians who treat diabetes on aspects of drug delivery and drug treatment for diabetes, enabling interested stakeholders to gain insight
Datamonitor, Dec 2008, Pages: 115
sales segmentation 92
Stakeholder Opinions: Type 2 Diabetes in the UAE & Saudi Arabia - Growth Opportunities in Fragmented Markets
Business Insights, Oct 2011, Pages: 112
the viewpoint of pharmaceutical companies, payers, and healthcare providers. Reforms and implications for various stakeholders are assessed and comments from 23 managers at Chinese hospitals included.
Features
Markets and Markets, Feb 2011, Pages: 253
and industry specific challenges.
- To analyze the trends and forecasts of the injectable drug delivery market and its segments
- To identify the major stakeholders in the market and draw a competitive
Decision Resources, Inc., Nov 2011
safety signal are likely to face regulatory requirements similar to those of diabetes agents. Navigating the stringent regulatory requirements for cardiovascular safety is therefore becoming increasingly
Frost & Sullivan, June 2010, Pages: 53
This study encompasses feedback provided by U.S. patients on aspects of drug delivery and drug treatment for chronic pain, enabling interested stakeholders to gain insight into current and future
Decision Resources, Inc., May 2009, Pages: 40
and tables, as well as insights from Decision Resources analysts.
Questions Answered in this report:
- Most personal health expenditures in the United States are spent on indications that greatly affect
Decision Resources, Inc., Aug 2010, Pages: 49
and enzyme replacement therapies (ERTs; biologics based on therapeutic recombinant enzymes) are great in metabolic disease markets.
In this report, we look beyond the dominant and well-documented diabetes
Datamonitor, Sep 2008, Pages: 108
their portfolio offering 61
Figure 27: Drivers and resistors of exiting a therapy area following a portfolio challenging event 62
Figure 28: Eli Lillys diabetes portfolio aims to satisfy a range of stakeholders 77
Datamonitor, Dec 2009, Pages: 160
as targeting of early-stage patients, who are more likely to mount a sufficient immune response.
Candidates for the treatment of substance dependence and diabetes have advanced furthest, whereas experts
GlobalData, Nov 2011, Pages: 82
the stakeholders of dialysis services, including public providers, private individual providers and private companies.
Reasons to buy
- Develop business strategies by understanding the trends and developments
Decision Resources, Inc., Sep 2008, Pages: 37
strategies, direct-to-consumer marketing.
- Two Spectrum, Personalized Medicine Scorecards: Executive insights from transcripts of Lilly and Roche company presentations to investors.
- Expert commentaries
Markets and Markets, Feb 2011, Pages: 264
market and its segments
- To identify major stakeholders in the market and draw a competitive landscape for market leaders for each of the drug delivery technology market.
- To analyze opportunities
GBI Research, Dec 2009, Pages: 71
of the major issues affecting the stakeholders of the direct to consumer (DTC) advertising market in the US and Europe. It discusses the major changes that have been observed after the relaxation of rules over
Datamonitor, July 2009, Pages: 53
of the different types of risk-sharing agreements adopted by manufacturers
- Insight into the utilization of such schemes in the UK, US, Italy and Australia
- Examination of the pros and cons of risk-sharing
GlobalData, Feb 2009, Pages: 31
North America Negative Pressure Wound Therapy (NPWT) Market: Strategic Market Analysis and Insight to 2012
Summary
Our “Issue Report” is an essential source of data and analysis on key medical
Global Markets Direct, Dec 2009, Pages: 115
? These are among the many questions that will be answered with insightful analysis in this report. The report analyses the ten major trends expected to influence the future of the global medical equipment industry
